Inserm Newsroom - Press room of the French national institute of health and medical research

21 September 2013: World Alzheimer Day

The 20th World Alzheimer’s Day is to be held on 21 September 2013. The main aim of this international day is to reflect on ways to improve the quality of life of patients and carers. Today, over 850,000 people are living with this disease. This day was the occasion for the Alzheimer Foundation, hosted by […]

(French) : Journée mondiale de la maladie d’Alzheimer

A l’occasion de la journée mondiale de la maladie d’Alzheimer qui se tiendra le 21 septembre 2013, le service de presse de l’Inserm vous compile les dernières actualités/avancées sur cette maladie.

IgNobels 2013 awards

10 September: World Suicide Prevention Day

The International Association for the Prevention of Suicide is working with WHO to hold this World Prevention Day to raise awareness about the number of lives lost due to suicide. Decreasing the number of suicides is a major public health issue which is part of a wider aim to reduce early mortality (mortality before the […]

Prevention of risk of sudden death in epilepsy

Sudden unexpected death in epilepsy (SUDEP) is one of the most frequent causes of sudden non-accidental death in young adults. The origin of SUDEP remains unknown, since it generally occurs at night, unwitnessed. SUDEP sometimes occurs in hospital, while the vital functions are being monitored and recorded. These are the data that Prof. Philippe Ryvlin, […]

FIBRO-TARGETS – Europe banks on cardiac fibrosis as a therapeutic target in heart failure

The European Union commits funds to the FIBRO-TARGETS research consortium

(French) : Les bienfaits d’une nouvelle molécule dans l’angioplastie coronaire

Menée par le Pr Philippe Gabriel Steg, de l’hôpital Bichat, (AP-HP) et l’équipe de recherche affiliée au Département Hospitalo-Universitaire FIRE, à l’Université Paris-Diderot et à l’Unité Inserm U-698, l’étude a porté sur plus de 24 000 patients traités par angioplastie et sur un nouveau traitement antiplaquettaire injectable inhibant la formation des caillots de plaquettes, le cangrelor. Les chercheurs ont analysé la totalité des résultats obtenus avec ce nouveau traitement comparé au traitement conventionnel. Ce nouveau médicament, fabriqué par The Medicines Company, n’est pas encore approuvé pour l’utilisation clinique et est encore expérimental.

French Cyclists of the Tour de France live 6 years longer that the general population

De Tom Simpson à Marco Pantani et Laurent Fignon, de nombreux cyclistes professionnels ont perdu la vie prématurément. Pour autant, depuis plus de 20 ans et dans de nombreuses disciplines, plusieurs études ont montré que les sportifs présentaient une durée de vie supérieure à la moyenne.

Circumcision effectively reduces the risk of HIV infection “in real life”

The ANRS-12126 “Bophelo Pele” Project implemented in the township of Orange Farm in South Africa has confirmed the effectiveness of a large-scale program of voluntary medical male circumcision in prevention of heterosexually acquired HIV infection. The follow-up of over 3300 men shows a 57% to 61% reduction in the rate of new HIV infections in circumcised men compared with uncircumcised men.

Rich or poor in intestinal bacteria: we are not all equal when it comes to obesity-related conditions

They observed that these individuals were deficient in intestinal bacteria (in both quantity and diversity) and were at greater risk of developing cardio-metabolic diseases.